Adjuvant (A091903)
- Result Type
- clinical trial
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Status: Active, Recruiting
9results found for:
Adjuvant (Moderna Keynote 942)
- Result Type
- clinical trial
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Patients With High-Risk Melanoma
Status: Active, Recruiting
Castle DECIDE
- Result Type
- clinical trial
DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes
Status: Active, Recruiting
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
- Result Type
- clinical trial
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
IOV-MEL-301 (TILVANCE-301)
- Result Type
- clinical trial
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma
Status: Active, Recruiting
Metastatic (CPMC19-MEL01)
- Result Type
- clinical trial
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Status: Active, Recruiting
Metastatic (ECOG-ACRIN EA6141)
- Result Type
- clinical trial
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Status: Active, Recruiting
Metastatic (Ideaya Biosciences IDE196-001)
- Result Type
- clinical trial
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Status: Active, Recruiting
Targeted Therapy (ASCO TAPUR)
- Result Type
- clinical trial
Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Active, Recruiting